chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sweating; Lethargy; Dizziness; Diarrhea; Aches; Chills; Fever (100.9°F); A spontaneous report  was received from a consumer concerning a 74-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, fever (100.9 F), aches, diarrhea, sweating, lethargy and dizziness.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 2 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 025J20-2A) intramuscularly for prophylaxis of COVID-19 infection.  On 5 Feb 2021, the patient experienced the events- chills, fever (100.9 F), aches, diarrhea, sweating, lethargy and dizziness. Lab data performed on the same day included body temperature:100.9 F (high).  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  The outcome of events- chills, fever (100.9 F), aches, diarrhea, sweating, lethargy and dizziness - were unknown.
According to parent on forecast pt was due for rotavirus. Pt at the age of 27 weeks was given ROTARIX. Informed provider of the action and stated pt was past the age range of receiving ROTARIX. No reaction at the time of vaccine given.
She broke out and got shingles. They did she did say it was in her eye but they lucky enough, they caught in time; I broke out on shingles and symptoms started before that; This is a spontaneous report from a contact female consumer (patient herself) via Pfizer-sponsored program. A 57-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EW0186, expiry date: unknown) via unspecified route of administration, in right arm on 28Jun2021 (age at vaccination: 57-years) as dose 2, single for covid-19 immunisation. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EW0180, expiry date: unknown) via unspecified route of administration, in left arm on 30May2021 (age at vaccination: 57-years) as dose 1, single for covid-19 immunisation. Vaccine facility type was pharmacy. Medical history of patient was not reported. Concomitant medications included levothyroxine, taken for unspecified indication, start and stop date not reported. Caller said she was normally a very heathy person but she got the second dose of the Pfizer covid-19 vaccine and a few days later she broke out and got shingles. They did she did say it was in her eye but they lucky enough, they caught in time and she just called us because she wanted to report this. She said lot of you know people need to be reporting the side effects so we know what is going on so that is the reason she called and she did know that she was being recorded in your department. Consumer stated, she received the Pfizer vaccine and within a month to the day after that I broke out on shingles and symptoms started before that but like she said was just curious that it was within a month that she had shingles and she have never had shingles and was always the healthiest person in the family. Treatment was taken in response to adverse events was with Valacyclovir, as traditional 10 days supply for shingles. Prior vaccination within 4 weeks of getting the Pfizer vaccine patient did not take any other vaccine. The outcome of the event was unknown.   Follow-up attempts are completed. No further information is expected.
PATIENT EXPERIENCED PALENESS, SWEATING, DIZZINESS, LIGHTHEADEDNESS. SHE FELT THAT SHE HAD A SEIZURE.
-Severe acid reflux-   2nd day and 3rd day after injection at 2-3 AM ( on an empty stomach).  Took antacids and stood up, lasted 1 1/2 hrs. 4th day very mild reflux.   Took antacid, cleared up within minutes. Do not normally have acid reflux -Rash on neck, back and front of neck ,behind ears, and on back, and some of my head . itchy rash. Occurred 5 days after injection:  treated with cortizone ointment and Benadryl. Milder but not quite gone.
Lab results drawn 11.13.07 (day after vaccine given) showed critical values: WBC 2.6. Pathologist reviewed = leukopenia. Patient had stopped Simvastin 3 weeks prior but was taking Diazide (which has known although rare instances of leukopenia). Stopped Diazide 11.13.07, repeat lab 11.14.07 showed normalized WBC.
Fever, chills, uncontrollable itching, small hives, map like rash on face, chest, shoulders, back, neck and chest.
Patient reports she received the COVID-19 vaccination "around 3:45pm on Friday, March 5th". States she left clinic in good condition after waiting the designated amount of time for observation. Reports that in the "middle of the night, she had terrible pain" described as throbbing and rated 10/10 and "that made her cry". Reports pain was "at the top of her shoulder, on the bone". Also states "he top of her shoulder, on the bone' as the injection site. Denies any swelling, redness, rash, or bruising at the site. Reports she lost range of motion and couldn't mover her own arm. States she "had her husband do passive range of motion for her".
having headaches again which she attributes to the high blood pressure; muscle pain; eye pain; arm soreness; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (eye pain), PAIN IN EXTREMITY (arm soreness), FATIGUE (fatigue), HEADACHE (headache) and HEADACHE (having headaches again which she attributes to the high blood pressure) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's medical history was not provided.  Concomitant products included BUTALBITAL, CAFFEINE, PARACETAMOL (FIORICET) for an unknown indication.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced EYE PAIN (eye pain), PAIN IN EXTREMITY (arm soreness), FATIGUE (fatigue) and MYALGIA (muscle pain). 17-Feb-2021, the patient experienced HEADACHE (headache). On 19-Mar-2021, the patient experienced HEADACHE (having headaches again which she attributes to the high blood pressure). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, EYE PAIN (eye pain), PAIN IN EXTREMITY (arm soreness), HEADACHE (having headaches again which she attributes to the high blood pressure) and MYALGIA (muscle pain) outcome was unknown and FATIGUE (fatigue) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Mar-2021, Hypertension: high (High) blood pressure was elevated.         Patient did not start  medications for BP but has told  to monitor and return in a month for re-evaluation.   Most recent FOLLOW-UP information incorporated above includes: On 19-Mar-2021: follow-up received and Additional event (headache), event outcome and laboratory test were updated.
patient received first dose for Shingrix in 2021 and then a second dose in 2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 81-year-old female patient who received Herpes zoster (Shingrix) (batch number 7KB9, expiry date 17-FEB-2024) for prophylaxis.   Previously administered products included Shingrix (patient received first dose of Shingrix on 16th July 2021, batch number MB7RR and expiry date 8th October 2022).   On 14-FEB-2023, the patient received the 2nd dose of Shingrix. On 14-FEB-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: patient received first dose for Shingrix in 2021 and then a second dose in 2023). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 18-MAY-2023 Pharmacist called to report that the patient received 2nd dose in 2023. The vaccine administration facility was same as the primary reporter. The patient received the 2nd dose of Shingrix later than recommended interval, which led to lengthening of vaccination schedule. The reporter consented to follow up via email.
The patient had a breakthrough COVID infection on 10/26/21. He presented to the hospital with fever and confusion on 10/26/21.
10mins post vaccination pt c/o Dizziness. Vitals: BP 133/92, HR 74, RR 20 Pt given water, juice and crackers.  Pt stable and released from the vaccination site.
Ringing in ears.  Left ear is worse that right ear.  I had ear ringing after my first J&J vaccine in 4/21 and first Moderna booster in 10/21, but in both cases, the ringing  went away within 48 hours after the shot.  In this case, the ringing has not gone away.  I have not previously had any issues with ear ringing.
The pneumonia vaccine was given in my left arm at around 10:30 A.M. on 03/06/2009. I began experiencing the usual pain and fever at the injection site by 7:00 A.M. on 03/07/09. By around 2:00 P.M., I began having pain in all major joints. By 5:00 P.M. I also started experiencing  a headache. I checked my temperature at that time and it was around 99.8. I took two ibuprofen, but they did not seem to have any affect on fever or pain. By 9:00 P.M. my temperature had risen to 101.7, it was extremely painful to move my arm and I had begun to feel as though my lungs were slightly inflamed (a kind of tightness in my chest with an inability to take a truly deep breath). At that point I took 3 aspirin and fell asleep. I woke up and checked my temperature again at around 10:30 P.M. and it had risen slightly to 101.8. I did not sleep well and woke repeatedly through out the night. I kept checking my temperature because I planned to head to the hospital if it went over 102, but it never did. I took two more aspirin at around 3:00 A.M then slept fitfully until around 9:00 A.M. on 03/08/09. By that time my temperature had finally dropped to around 100.8. The injection site was still slightly swollen and pink and still very sore. As the day wore on my fever gradually dropped to 99.5 where it stayed until around 7:00 P.M. when it jumped back up slightly to 100. I took two more aspirin then and fell asleep at around 9:00 P.M. When I woke up at 6:00 A.M. on 03/09/09, my arm was still a little sore and slightly pink around the injection site. My temperature had dropped to 96.8 and I had a lingering headache and felt tired and washed out the remainder of the day.
Pt reported flushing/sweating and lightheadedness.  Vitals: 112/50,59,22 Pt given ammonia ampule and fruit juice.  Pt stable and released from the vaccination site.
Liquid diarrhea; Soreness; headache; brain fog; This is a spontaneous report from a contactable consumer. A 53-year-old non-pregnant female consumer received first bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot Number: En6199), via an unspecified route of administration, administered in right arm on 05Mar2021 03:45 PM (at the age of 53-year-old) at single dose for COVID-19 immunization at the hospital. The patient medical history included Bc 2017; thyroid 2020; hbp 2010. The patient had no allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications in two weeks included tamoxifen, levothyroxine sodium (SYNTHROID) and Lisinopril-all medications taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient did not received other vaccines. On an unspecified date the patient experienced liquid diarrhea, 02hours after continued soreness, headache and brain fog. The patient did not received any treatment for the adverse events. The outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
Chills; Bad headache; Rash on her armpits and back of her neck; Lethargic; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9269), via an unspecified route of administration in left arm, on 10Feb2021 at 01:45 PM (13:45) (at the age of 69 years), as dose 2, single, for COVID-19 immunization. The patient's medical history included rheumatoid and osteoarthritis. The patient's concomitant medications included unspecified medications. The patient previously received the first dose of BNT162B2 (Lot Number: EL9262) on 20Jan2021 at 10:45 AM (at the age of 69 years) for COVID-19 immunization with no reaction at all (right arm). The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The most recent vaccine was administered in a public health clinic or Veterans administration facility. On 11Feb2021 at 01:00 AM, the patient experienced 4 to 5 hours of chills during the night with a bad headache. On the next morning (11Feb2021), the patient had a rash on her armpits and back of her neck (chills and headache were gone) and she was lethargic all day. The patient went to work the next day. The patient was administered with the vaccine on a Wednesday (10Feb2021) and she was back to work on Friday (12Feb2021). No treatment was received for the adverse events. The patient had not been tested for COVID-19 post vaccination. The patient recovered from "Chills" and "Bad headache" on 11Feb2021 (unspecified time); and from the remaining events in Feb2021.   No follow-up attempts are possible. No further information is expected.
Patient was covid-19 positive 9/14/2020 with no hospitalization. Received 2 doses Moderna covid-19 vaccine January 2021 and February 2021. Patient tested positive for covid-19 on 8/26/2021 with mild symtpoms and no hospitalization or other complications.
MISSED TO TAKE THE FOURTH DOSE; This spontaneous case (PVX2019-843) was received from a consumer on 09-Apr-2019. It describes a male consumer who "missed to take the fourth dose". The consumer was receiving oral Vivotif for typhoid fever prophylaxis.   Case report: The consumer took 3 doses of Vivotif. After that, she went out of town over the weekend and did not carry the last dose. Thus, she missed her last dose.  Action taken with Vivotif was not applicable.   The clinical outcome of the event "missed to take the fourth dose" was unknown.  Company's Comment: The causality of the event "missed to take the fourth dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "missed to take the fourth dose" was considered as not applicable.
The pt reported pulsating in fingers and toes, "a little dizzy and ringing in ears".   BP-144/78, HR-74, O2 - 93%, RA.  Pt offered water and a snack.  Pt closely monitored for 30 mins.  Pt verbalized feeling better before departure.  Pt left in stable condition.
he's experiencing fever; terrible fatigue; body aches; severe sight pain; This is a spontaneous report from a Pfizer. A contactable consumer reporting for her husband. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14May2021 (Batch/Lot number was not reported) as 2nd dose, single for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Apr2021 for Covid-19 immunization. In May2021, after 2nd dose, the patient had been experiencing fever, terrible fatigue, body aches, severe sight pain and he even took TYLENOL but he was experiencing worse. The patient's wife was worried about his situation now. The outcome of the events was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
No adverse effects reported; two patients were administrated an improperly stored dose of PNEUMOVAX 23; This spontaneous report was received from a nurse and refers to an identifiable patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On 16-SEP-2019, the patient was vaccinated with improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), lot # S013489, expiration date 06-MAR-2021 (strength, route of administration and exact dose were not reported) for prophylaxis. No adverse effects were reported. Administered dose of vaccine experienced the temperature excursion of above 9 Celsius degrees (also reported as 16.8 Celsius degrees) for 3 hours. The digital data logger was involved in recording the temperature excursion details. There were no previous excursions reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1909USA008031:
Information has been received from a MA concerning a pt who in 2004 was vaccinated with a dose of PNEUMOVAX 23 vaccine. Subsequently, the pt developed erythema and swelling of the arm. Unspecified medical attention was sought. Subsequently, the pt recovered. No product quality complaint was involved.  Additional information has been requested. It was also reported that 2 other pt's were vaccinated with a dose of PNEUMOVAX 23 vaccine and developed adverse reactions (WAES # 0405USA01451 & 0405USA02064).
left shoulder was still sore where he got the shot; Headache; This is a spontaneous report received from a contactable consumer, the patient. A 64-years-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE),via an unspecified route of administration in the left arm on 09Mar2021 11:00 (Batch/Lot Number: unknown; expiration date: unknown; NDC number: unknown) (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included the patient had occasionally headaches and took acetaminophen, aspirin and caffeine off and on as needed for headaches. Concomitant medications were not reported. On 09Mar2021, shortly after when he was leaving and driving, he started getting a headache and he took two acetaminophen, aspirin and caffeine (EXCEDRIN) at lunch time. His head started hurting about half an hour after the vaccination. The headache kind of went away after the lunch. On an unspecified date, the patient stated that left shoulder was still sore where he got the shot. The outcome of event, headache was recovered on 09Mar2021 as the headache was gone and the outcome of event, left shoulder was still sore where he got the shot was not recovered.   The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
Patient claims loss of taste/smell since second dose of Covid vaccine.  He did have Covid 2 months prior but claims no taste/smell loss until second Covid vaccine dose.
Subsequent to receiving one dose of varicella virus vaccine live the pt developed chickenpox that consisted of approximately 30 lesions located from the waist up. Pt had itching and a temperature of 99.1F. The physician felt that chickenpox was not related to therapy with varicella virus vaccine live.
This child spiked a temp approximately 1 week later. He became more hyperactive, ceased taking daily naps, between 16 months and 18 months of age. Severe ADHD w developmental delay.
05/26/2022 I came down with COVID-19 symptoms, gland swelling in my throat, and also a scratchy throat. By Thursday night they swelled up quite a bit and I was having difficulty swallowing. Friday I did a home test for COVID-19 and it came back positive quickly. I then started to try and find an appointment, however I was unsuccessful. Saturday morning I then went to the ER and I was feeling short of breath slightly with difficulty of breathing and the swelling in my neck was really bad. At the ER their pulse Ox was showing 96 and a Chest X-Ray Interstitial Pneumonitis, and soft tissue of neck showed nothing abnormal. I did have a low grade temp at 101. I did not have nasal congestion however my ears were extremely full, and a headache. Blood Pressure was also high at the time out of my norm. My voice did get affected as well a few days later that changed to a deeper tone. Laying down flat showed my pulse oximeter was at 92 so I propped myself up with pillows and it returned to normal. I did receive PAXLOVID. Symptoms did not improve after taking PAXLOVID, I went to urgent care for a follow up and my doctor was unfortunately very dismissive with COVID-19 and examined I had a sinus infection. I was given antibiotics which I did not fill. I took over the counter cough medicine. I still had the swollen neck for a total of 10 days and head congestion and pressure for about 2 weeks total. I would say that by the 3rd week I started to improve. I had trouble eating because it would cause pain in my stomach after ingesting. Symptoms that were still present a little while after the infection were brain fog, trouble with short term memory as well. Sleep Apnea seems to have come up as a new symptom that has come after sleep apnea.
p/ pt recv vax devel upper resp sx, malaise, fever 101f; bacterial pneumonia, nodule rt mid-lung. adenopathy, dry cough; 5/29 devel varicella zoster rash w/40 lesions, scattered papules, previous SOB, imp papule/small vesicles, vax strain p
This report describes the occurrence of autism spectrum disorder and mercury poisoning in a male child of unspecified age who was vaccinated with diphtheria and tetanus toxoids and pertussis vaccine and hepatitis B vaccine for prophylaxis. This report was received as part of litigation proceedings, with forwarding of limited medical records. The subject's medical history, concurrent conditions, and concurrent medications were not reported. The subject received injections of diphtheria and tetanus toxoids and pertussis vaccine on 7/21/98, 9/28/98, 11/16/98, and 11/19/99. He also received injections of hepatitis B vaccine, haemophilus influenzae type B conjugate vaccine, inactivated poliomyelitis virus vaccine, MMR, and varicella virus vaccine. The subject's attorney alleged that, as a result of the vaccines administered, the subject suffers from the effects of mercury poisoning. The attorney forwarded a form used by the pediatrician to certify that the subject could participate in physical education. In the general comments section of the form, the pediatrician wrote, Autistic Spectrum Disorder. The autism spectrum disorder and mercury poisoning in this report are considered medically serious.
At time of injection the left side of my face, left arm and left leg went numb. Was numb for about 3 hours and now 4 weeks later it still comes and goes. Right now my left leg has been numb for over a half hour for no reason.
pt recv vax;began having focal sz;rt hand twitching;lasted 5 min&occurred on 3 episodes;mild apnea w/ last sz;given dilantin&sz stopped;
Child became ill with fever of 103 on February 16.  24 hours later broke out with chicken pox.  10 days later her twin sister broke out and following that this child broke out again.  Less than thirty lesions.